Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter C. Kohler, Jacquelyn A. Hank, Karen H. Moore, Barry Storer, Robin Bechhofer, Richard Hong & Paul M. Sondel. (1989) Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous Infusion. Cancer Investigation 7:3, pages 213-223.
Read now
Read now
W. K. Dowjat, L. J. Quackenbush & M. B. Zaleski. (1985) Strain differences in the response of normal murine spleen cells to interleukin-2 (IL-2). Immunological Investigations 14:6, pages 493-501.
Read now
Read now
Articles from other publishers (18)
Marcello Pinti, Paolo Salomoni & Andrea Cossarizza. (2006) Anti-HIV drugs and the mitochondria. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1757:5-6, pages 700-707.
Crossref
Crossref
Benjamin A. Kruskal & R. Alan B. Ezekowitz. (1994) Cytokines in the treatment of primary immunodeficiency. Biotherapy 7:3-4, pages 249-259.
Crossref
Crossref
Benjamin A. Kruskal & R. Alan B. Ezekowitz. 1995. Cytokines in the Treatment of Infectious Diseases. Cytokines in the Treatment of Infectious Diseases
249
259
.
Yasunobu Nakano, Susan Pross & Herman Friedman. (1993) Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages. Life Sciences 52:1, pages 41-51.
Crossref
Crossref
Cindy K. Angerhofer & John M. Pezzuto. 1993. Biotechnology and Pharmacy. Biotechnology and Pharmacy
312
365
.
Susan Pross, Yasunobu Nakano, Sharon Bowen, Ray Widen & Herman Friedman. 1993. Drugs of Abuse, Immunity, and AIDS. Drugs of Abuse, Immunity, and AIDS
73
80
.
Avi Hassner & Daniel C. Adelman. (1991) Biologic Response Modifiers in Primary Immunodeficiency Disorders. Annals of Internal Medicine 115:4, pages 294-307.
Crossref
Crossref
Richard M. Bauer, Melinda J. Tarr & Richard G. Olsen. (1990) Effect of 1,1-dimethylhydrazine on lymphoproliferation and interleukin 2 immunoregulatory function. Archives of Environmental Contamination and Toxicology 19:1, pages 148-153.
Crossref
Crossref
R. Pahwa, C. Paradise & R.A. Good. (1989) Management of a novel immune deficiency with IL-2 therapy. Cancer Treatment Reviews 16, pages 143-149.
Crossref
Crossref
Derry Ridgway & Michael S. Borzy. (1989) Elevated production of interleukin-2 by lymphocytes from children with acute leukemia. The Journal of Pediatrics 114:3, pages 384-391.
Crossref
Crossref
Misao Ide, Kazue Kaneda, Kenzo Koizumi, Kanji Hojo, Yasuo Murai, Keiko Sagawa, Masao Kono & Kosaburo Sato. (1987) Neutralizing monoclonal antibodies against recombinant human interleukin-2. Journal of Immunological Methods 101:1, pages 57-62.
Crossref
Crossref
A.M. ATTALLAH & A.H. HAKIM. 1987. Lymphokines. Lymphokines
443
455
.
Edward R. Sherwood, David L. Williams, Rose B. McNamee, Ernest L. Jones, I.William Browder & Nicholas R. Di Luzio. (1987) Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. International Journal of Immunopharmacology 9:3, pages 261-267.
Crossref
Crossref
Mohan M. Reddy & Michael H. Grieco. (1987) In vitro immunomodulatory effects of interleukin-2 and thymosin fraction V in acquired immune deficiency syndrome. International Journal of Immunopharmacology 9:4, pages 483-488.
Crossref
Crossref
Mark Lyte. (2005) Generation and measurement of interleukin‐1, interleukin‐2, and mitogen levels in small volumes of whole blood. Journal of Clinical Laboratory Analysis 1:1, pages 83-88.
Crossref
Crossref
R. Mertelsmann & K. Welte. (1986) Human Interleukin 2: Molecular Biology, Physiology and Clinical Possibilities. Immunobiology 172:3-5, pages 400-419.
Crossref
Crossref
E.W. Ades, A. Hinson & L.D. Butler. (1986) Natural cytolytic activity in mice with natural or induced cellular defects. Cellular Immunology 101:1, pages 15-23.
Crossref
Crossref
Thomas A. Waldmann. (1986) The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes. Science 232:4751, pages 727-732.
Crossref
Crossref